Tesamorelin and sermorelin both tell your pituitary gland to release more of your own growth hormone. The difference is strength, staying power, and evidence. Tesamorelin is a stabilized, full-length GHRH analog with large clinical trials showing a 15–20% reduction in visceral belly fat. Sermorelin is a shorter GHRH fragment that produces a gentler, shorter growth-hormone pulse and is typically used for sleep, recovery, and general healthy-aging goals.
The short answer: choose tesamorelin if your main goal is losing stubborn abdominal and visceral fat. Choose sermorelin if you want a milder way to support natural growth hormone, sleep quality, and recovery.
The core difference is structure. Sermorelin is a copy of only the first 29 amino acids of growth hormone-releasing hormone (GHRH), the minimum portion needed to trigger growth hormone release. Tesamorelin is the complete 44-amino-acid GHRH chain with an added chemical modification that shields it from DPP-4, the enzyme that breaks natural GHRH down within minutes.
That single design choice explains nearly every other difference between them:
Both peptides use the same basic mechanism:
Neither peptide is growth hormone. They work upstream, which means your body's normal feedback systems stay in place. When growth hormone rises, the hypothalamus releases somatostatin to put on the brakes. This natural ceiling is a major reason people choose GHRH peptides over injecting synthetic HGH.
The key difference is magnitude. In a study of healthy men, two weeks of tesamorelin raised IGF-1 by about 181 µg/L while increasing both basal and pulsatile GH secretion. Sermorelin's shorter half-life produces a more modest and shorter-lived response — useful for gentle support, but less powerful for targeted fat loss.
Tesamorelin is clearly better for belly fat. It is the most studied GHRH peptide for visceral fat — the deep abdominal fat that wraps around organs and drives insulin resistance, high triglycerides, and fatty liver.
In a landmark trial published in the New England Journal of Medicine, 412 adults with excess abdominal fat took 2 mg of tesamorelin or placebo daily for 26 weeks. Visceral fat fell by 15.2% with tesamorelin and rose by 5% with placebo. Triglycerides dropped by 50 mg/dL and the cholesterol-to-HDL ratio improved.
A pooled analysis of two phase 3 trials confirmed the results, with the largest reductions in people who started with the most visceral fat, and with benefits maintained through 52 weeks of continued treatment. Importantly, tesamorelin reduced visceral fat while largely preserving subcutaneous fat, the more benign fat under the skin.
Sermorelin does not have comparable data. In a 16-week study of older adults using a GHRH(1-29) analog, lean body mass increased in men, but overall body fat did not change significantly. In another study of older men, six weeks of nightly GHRH(1-29) did not change DEXA fat measurements or waist-to-hip ratio.
Bottom line: if your goal is a smaller waist or less abdominal fat, tesamorelin is the stronger choice. Neither peptide is a replacement for a calorie-controlled diet — and for significant scale-weight loss, a GLP-1 medication such as tirzepatide is a different, more powerful category. Compare the options in our guide to the best peptides for fat loss.
Neither peptide is a steroid, and neither will build muscle on its own. Both support the anabolic environment by raising growth hormone and IGF-1.
For body recomposition — losing fat while holding or gaining lean mass — tesamorelin has the stronger case. For a gentler recovery-focused protocol, sermorelin is a reasonable starting point. For lifters who want a stronger GH pulse from two complementary pathways, CJC-1295 with ipamorelin is the other common option. See the full list in our guide to the best peptides for muscle growth.
Sermorelin is the more common choice for sleep. The largest natural growth hormone pulse of the day happens shortly after you fall asleep, during deep slow-wave sleep. Sermorelin is taken before bed to amplify that pulse, and many people report deeper, more restorative sleep within the first few weeks.
Tesamorelin is also typically taken at night and can support the same overnight GH rhythm, but it is chosen primarily for body composition rather than sleep.
If sleep is your main goal, compare sermorelin with other options in our guide to the best peptides for sleep.
Tesamorelin has one of the more interesting cognitive studies of any peptide. In a 20-week randomized, placebo-controlled trial of 152 adults aged 55–87, nightly tesamorelin improved executive function in both healthy older adults and people with mild cognitive impairment. IGF-1 rose by 117% while staying within the normal physiological range, and body fat fell by 7.4%.
Sermorelin does not have a comparable controlled cognitive trial, although better sleep often translates into better daytime focus and energy.
Visceral fat and liver fat travel together, and tesamorelin reduces both. In a randomized trial in JAMA, six months of tesamorelin reduced liver fat alongside visceral fat. A later multicenter trial in people with non-alcoholic fatty liver disease found tesamorelin reduced liver fat by 37% relative to baseline, and 35% of patients reached a normal liver-fat level versus 4% on placebo.
Sermorelin has not been studied for liver fat in the same way. For people with metabolic goals centered on the waist and liver, tesamorelin is the evidence-based pick.
Growth hormone output falls by roughly 14% per decade after early adulthood, which contributes to slower recovery, thinner skin, more abdominal fat, and less lean mass. Both peptides aim to restore a more youthful GH pattern without the downsides of synthetic HGH.
A practical way to think about it: sermorelin is the gentle "maintenance" option, while tesamorelin is the "targeted results" option.
Sermorelin's effects on sleep and recovery tend to be the first thing people notice, often within the first few weeks. Tesamorelin's signature benefit — visceral-fat reduction — is slower to show because fat loss accumulates over months, with the largest measured changes in trials at around six months.
When comparing the two, track waist measurements and body-composition scans rather than scale weight. Visceral-fat loss can shrink your waist while the scale barely moves.
Because both act on the same receptor, their side-effect profiles overlap: injection-site redness, brief flushing, and mild headache are the most common with either.
The difference comes down to strength. Tesamorelin's larger IGF-1 increase makes fluid retention, joint aches, and a modest rise in blood sugar somewhat more likely. Sermorelin's shorter pulse generally means milder, more transient effects, with flushing right after injection being the most commonly reported.
Stacking them is generally not recommended. Both bind the same GHRH receptor, so combining them doesn't add a meaningfully different mechanism.
If you want to amplify a GHRH peptide, the more logical pairing is a GHRH analog plus a ghrelin-receptor agonist (GHRP) such as ipamorelin. These act on two different receptors and work synergistically — the same principle behind CJC-1295 and ipamorelin.
GHRH peptides preserve the body's natural rhythm and feedback loops, which is why they are often preferred over synthetic HGH for adults who don't have diagnosed growth hormone deficiency. Learn more in our guide on how to increase growth hormone.
Choose tesamorelin if you:
Choose sermorelin if you:
Many people start with sermorelin for general wellness and move to tesamorelin once body composition — especially abdominal fat — becomes the priority.
Yes. Tesamorelin is a stabilized, full-length GHRH analog with a longer half-life, so it produces a larger and more consistent increase in growth hormone and IGF-1 than sermorelin.
Tesamorelin. It is the only GHRH peptide with large randomized trials showing significant visceral-fat reduction — around 15–20% over 6–12 months. Sermorelin has not shown comparable fat-loss results.
No. Both are GHRH analogs that stimulate your own growth hormone, but sermorelin contains only the first 29 amino acids of GHRH, while tesamorelin is the full 44-amino-acid chain with a modification that makes it more stable and longer acting.
Yes. Because they work through the same receptor, switching is straightforward and does not typically require a washout period. Your clinician will adjust the protocol when you change.
No. Unlike synthetic HGH, both peptides stimulate your pituitary rather than replacing its output, so your natural feedback loops stay intact.
Largely, yes. Both are usually taken as a small subcutaneous injection at bedtime on an empty stomach, to line up with the body's largest natural growth hormone pulse during early sleep.
Both work in women. Tesamorelin tends to be the better fit for women focused on abdominal fat, while sermorelin suits women prioritizing sleep, skin, and recovery. See our guide to the best peptides for women.
Tesamorelin is usually the stronger choice for men looking to lose belly fat and improve body composition, while sermorelin is a good entry point for recovery and sleep. More options are covered in our guide to the best peptides for men.
Tesamorelin and sermorelin both raise your own growth hormone by stimulating the pituitary, but they are built for different goals. Tesamorelin is stronger, longer acting, and backed by large clinical trials for visceral fat, liver fat, and even cognition. Sermorelin is gentler and best suited to sleep, recovery, and general healthy-aging support.
If you're unsure which fits you, Bowery Clinic can match you with the right protocol after a quick online evaluation. Explore Tesamorelin or Sermorelin to get started.
